XML 83 R74.htm IDEA: XBRL DOCUMENT v3.22.0.1
Capital Stock (Stock Option, SARs, Restricted Stock and Restricted Share Unit Activity) (Details)
shares in Thousands
9 Months Ended
Dec. 31, 2021
$ / shares
shares
Class A Voting Shares | Stock Options and SARs  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Outstanding at March 31, 2021 (in shares) 5,500
Granted (in shares) 0
Options exercised (in shares) 0
Forfeited or expired (in shares) 0
Outstanding at December 31, 2021 (in shares) 5,500
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]  
Outstanding at March 31, 2021, weighted average exercise price (in usd per share) | $ / shares $ 24.23
Granted, weighted average exercise price (in usd per share) | $ / shares 0
Options exercised, weighted average exercise price (in usd per share) | $ / shares 10.84
Forfeited or expired, weighted average exercise price (in usd per share) | $ / shares 21.95
Outstanding at December 31, 2021, weighted average exercise price (in usd per share) | $ / shares $ 24.33
Class A Voting Shares | Restricted Stock and Restricted Share Units (RSUs)  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Outstanding at March 31, 2021 (in shares) 0
Granted (in shares) 0
Vested (in shares) 0
Forfeited or expired (in shares) 0
Outstanding at December 31, 2021 (in shares) 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Outstanding at March 31, 2021, weighted average grant-date fair value (in usd per share) | $ / shares $ 11.10
Granted, weighted average grant date fair value (in usd per share) | $ / shares 13.16
Restricted stock or RSUs vested, weighted average grant-date fair value (in usd per share) | $ / shares 12.05
Forfeited or expired, weighted average grant-date fair value (in usd per share) | $ / shares 0
Outstanding at December 31, 2021, weighted average grant-date fair value (in usd per share) | $ / shares $ 11.51
Class B Non-Voting Shares | Stock Options and SARs  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Outstanding at March 31, 2021 (in shares) 21,200
Granted (in shares) 1,200
Options exercised (in shares) (300)
Forfeited or expired (in shares) (400)
Outstanding at December 31, 2021 (in shares) 21,700
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]  
Outstanding at March 31, 2021, weighted average exercise price (in usd per share) | $ / shares $ 15.85
Granted, weighted average exercise price (in usd per share) | $ / shares 12.27
Options exercised, weighted average exercise price (in usd per share) | $ / shares 11.42
Forfeited or expired, weighted average exercise price (in usd per share) | $ / shares 24.62
Outstanding at December 31, 2021, weighted average exercise price (in usd per share) | $ / shares $ 15.55
Class B Non-Voting Shares | Restricted Stock and Restricted Share Units (RSUs)  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Outstanding at March 31, 2021 (in shares) 9,100
Granted (in shares) 4,700
Vested (in shares) (5,600)
Forfeited or expired (in shares) (500)
Outstanding at December 31, 2021 (in shares) 7,700
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Outstanding at March 31, 2021, weighted average grant-date fair value (in usd per share) | $ / shares $ 8.71
Granted, weighted average grant date fair value (in usd per share) | $ / shares 14.18
Restricted stock or RSUs vested, weighted average grant-date fair value (in usd per share) | $ / shares 9.05
Forfeited or expired, weighted average grant-date fair value (in usd per share) | $ / shares 9.34
Outstanding at December 31, 2021, weighted average grant-date fair value (in usd per share) | $ / shares $ 11.82
Maximum | Class A Voting Shares | Stock Options and SARs  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Options exercised (in shares) (100)
Forfeited or expired (in shares) (100)
Maximum | Class A Voting Shares | Restricted Stock and Restricted Share Units (RSUs)  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Outstanding at March 31, 2021 (in shares) 100
Granted (in shares) 100
Vested (in shares) (100)
Outstanding at December 31, 2021 (in shares) 100